Cambridge Healthtech Institute’s Inaugural
AI-Powered Drug and Target Discovery
Turning AI, Data, and Biology into Faster Discovery Decisions
January 19-20, 2027
Early discovery is being reshaped by the convergence of biological data, computational reasoning, and experimentally grounded validation. CHI’s Inaugural AI-Powered Drug and Target Discovery conference will examine how AI/ ML are transforming biologic drug discovery, from disease target identification and prioritization, to validation and advancement into molecular designs and therapeutic programs.
The agenda will explore how machine learning, foundation models, reasoning systems, multi-model models, active learning, screening data, and target intelligence platforms are strengthening biological hypotheses, assessing tractability, guiding modality selection, and improving discovery decisions. Sessions will examine where frontier models add value, how AI is reshaping scientific and early discovery workflows, and how AI scientist platforms and agentic systems can support literature synthesis, hypothesis generation, experimental planning, data analysis, and protein design while clarifying what still requires human judgment.
Coverage will include, but is not limited to:
- AI-Driven Target Discovery and Targeting
- Addressing Challenging Targets
- Foundation Models, Reasoning Models, and Target Intelligence
- AI Scientists and Lab-in-the-Loop Discovery
- Data Infrastructure and AI Ready Assays
- Agentic Workflows for Discovery and Engineering Teams
- Target Tractability, Modality Selection, and Candidate Prioritization
- Active Learning and Closed Loop Discovery
- Benchmarking AI for Drug Discovery Decisions
We are also seeking instructors and facilitators to lead the sessions below (in addition to the podium presentations):
- Competitions and benchmarking
- Interactive breakout discussions
- Demonstrations
- One day training seminars
- Working groups
The deadline for priority consideration is July 3, 2026.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: